FDA Inspection 1241023 — Merck Kommanditgesellschaft auf Aktien

Merck Kommanditgesellschaft auf Aktien — FEI 3002806906

The FDA completed an inspection of Merck Kommanditgesellschaft auf Aktien on October 6, 2023 in Darmstadt. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 6, 2023
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Darmstadt (Germany)

Additional Details

Mutual Recognition Agreement (MRA)